These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2298413)

  • 21. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin nuclear staining is useful for the diagnosis of ovarian adult granulosa cell tumor.
    Ohishi Y; Kurihara S; Takeuchi T; Aman M; Kaku T; Kobayashi H; Wake N; Oda Y
    Hum Pathol; 2012 Jun; 43(6):808-17. PubMed ID: 22079356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric DNA analysis of ovarian Brenner tumors and transitional cell carcinomas.
    Martin AR; Kotylo PK; Kennedy JC; Fineberg NS; Roth LM
    Int J Gynecol Pathol; 1992 Jul; 11(3):188-96. PubMed ID: 1399228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins.
    Miettinen M; Wahlstrom T; Virtanen I; Talerman A; Astengo-Osuna C
    Am J Surg Pathol; 1985 Sep; 9(9):640-51. PubMed ID: 2996374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA content of juvenile granulosa tumors determined by flow cytometry.
    Swanson SA; Norris HJ; Kelsten ML; Wheeler JE
    Int J Gynecol Pathol; 1990; 9(2):101-9. PubMed ID: 2332268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
    Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
    Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic study.
    Iversen OE; Skaarland E
    Cancer; 1987 Jul; 60(1):82-7. PubMed ID: 3581034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors.
    Mayr D; Kaltz-Wittmer C; Arbogast S; Amann G; Aust DE; Diebold J
    Mod Pathol; 2002 Sep; 15(9):951-7. PubMed ID: 12218213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ploidy analysis of epithelial ovarian cancers using image cytometry.
    Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
    Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
    Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
    Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
    Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
    Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
    Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.